BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).

Informazioni relative al progetto

BQ-Technology

ID dell’accordo di sovvenzione: 828120

DOI

10.3030/828120

Progetto chiuso

Data della firma CE 2 Agosto 2018

Data di avvio 1 Agosto 2018

Data di completamento 30 Novembre 2018

Finanziato da

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

BRAINQ TECHNOLOGIES LTD
Israel

Periodic Reporting for period 1 - BQ-Technology (BrainQ, non-invasive, very low intensity, BCI-based frequency dependent electromagnetic field tailored treatment for neuro recovery (BQ).)

Periodo di rendicontazione: 2018-08-01 al 2018-11-30

Sintesi del contesto e degli obiettivi generali del progetto

BrainQ is on a mission to revolutionise how we treat and manage neurological disorders such as stroke and spinal cord injury (SCI) through Artificial Intelligence (AI).
In the EU alone, the total cost of stroke to healthcare providers in 2015 was €45 Billion , with 72% of this being for direct in-hospital care based on data provided by SAFE (Stroke Alliance for Europe) . SCI, on the other hand, has lower incidence rates however still generates a substantial economic burden.
The overall onbjectives of BrainQ are related to the development and clinical validation of the innovative device, the BQ 1.0. The Phase 1 projects objectives are related to the technical and busienss feasibility assessment of the project.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

During the project, BrainQ reviewed the current stage of development and updated the development plan for the BQ 1.0. Within the duration of the project, the Company has also engaged with leading research hospitals in Italy and Spain. Discussions with these key stake holders have helped BrainQ palnning the clinical validation work foreseen in Europe.
The Company improved their understanding of the EU market and of the regulations affecting the commercialsiation of the BQ 1.0 in Europe.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The BQ 1.0 is an innovative Brain Computer Interface (BCI) - based device that provides a completely non-invasive treatment for a broad range of neurological conditions such as stroke, spinal cord injury (SCI), and traumatic brain injury (TBI). The development of the BQ 1.0 has brought BrainQ to create a large-scale data set of EEG motor tasks currently composed of over 100,000 motor tasks files. The device delivers an electromagnetic treatment that is expected to enhance motor function and overall rehabilitation outputs for thousands of patients suffering from neuro trauma with motor impairment.

BrainQ logo